login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
GVK BIO Enters into Drug Discovery Agreement With Wyeth Pharmaceuticals
GVK BIO will utilise in-house capabilities in discovery chemistry, informatics, biology and ADME to advance this program.
GVK BIO will be responsible for identifying drug candidates, which will be transferred to Wyeth to advance these compounds towards clinical studies.
Under the agreement, GVK BIO will receive an initial payment and will be eligible for success-based milestone payments.
G V Sanjay Reddy, Managing Director, GVK Biosciences said, "It is a momentous occasion for us. GVK BIO has had a successful partnership with Wyeth on various chemistry research activities dating to 2006.
This research agreement expands our work together and builds on GVK BIO's core strengths. This agreement further validates India's capability to do innovative research along with leading pharmaceutical and biotech companies".
Source-ANI
THK/L
|
|
More News on: Drug Toxicity, Clinical Trials, Clinical Trials - The Past and The Future , Clinical Trials - Different Phases of the trial , Signature Drug Toxicity
 Comment & Contribute
|
Medwonders Health Network
- Health News Index
|
|
- News Quick Links
| News Categories: |
| » | Gasoigne Swaps Booze for Botox |
| » | Michelle Obama: Name of Olive Tree in Italy |
| » | Beyonce: Most Beautiful Women in the World |
| » | Robin Gibb Recovers from Coma Wakes Up to Cancer |
| » | Botox and Vitamin Jabs Maintain Simon Cowell’s Young Looks |
| More Celebrity News | |
|
